Paradigm Diagnostics Receives Expanded Medicare Coverage for PCDx for Solid Tumors

By In The News
January 10, 2020 in The Headlines

Recommended Posts

In The News

Posted January 10, 2020

- Share

Posted January 10, 2020

PHOENIX, Jan. 10, 2020 /PRNewswire/ -- Paradigm Diagnostics, Inc. announced that Palmetto GBA, the Medicare Administrative Contractor (MAC) for the Molecular Diagnostics MolDX program, has reviewed the technical dossier and broadly approved the Paradigm Cancer Diagnostic (PCDx) assay...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  219848
2. Jaydee
  16742
3. Kip Powick
  12210
4. deicer
  12196
5. dagger
  9595
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.1k
- Total Posts
  
  558.6k

Sign In

Paradigm Diagnostics Receives Expanded Medicare Coverage for PCDx for Solid Tumors

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support